Status:
UNKNOWN
Measuring the Effects of Complementary Therapies in Chronic Neuropathic Pain
Lead Sponsor:
Chantal Berna
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The objective of the study is to a) assess the presence of a maladaptive stress response, a decreased pain modulation and any cognitive impairment in patients with chronic neuropathic pain in comparis...
Detailed Description
The current study, through two sub-studies, aims to investigate through clinical, psychophysical and biological methodology in a population of patients with chronic neuropathic pain (i.e. involving a ...
Eligibility Criteria
Inclusion
- Patients:
- Inclusion criteria:
- aged 18-90 years,
- interested in complementary medicine
- peripheral neuropathic pain lasting for more than 6 months,
- pain intensity of at least 3/10 VAS over the last two weeks
- Exclusion criteria:
- cognitive deficit (MMSE\<24/30),
- severe hearing impairment,
- acute psychiatric (e.g. suicidality, psychotic symptoms) or somatic (e.g. unstable cardiorespiratory condition) co-morbidity preventing full engagement in the 8-week study intervention,
- prior negative experience with hypnosis,
- allergy or intolerance to mannitol.
- Healthy controls:
- Inclusion Criteria:
- matching patients for age and gender,
- no chronic pain condition no acute pain condition requiring daily intake of analgesics,
- no acute medical or psychiatric condition.
Exclusion
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT03783624
Start Date
November 1 2018
End Date
October 1 2024
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lausanne University Hospital (CHUV)
Lausanne, Switzerland, 1011